Drug Shortage Report for SANDOZ PANTOPRAZOLE

Last updated on 2020-03-30 History
Report ID 83262
Drug Identification Number 02301083
Brand name SANDOZ PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 500
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-04-15
Estimated end date 2020-02-21
Actual end date 2020-02-28
Shortage status Resolved
Updated date 2020-03-30
Company comments - Sandoz is supplying the market with limited inventory based on historical demand
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-03-30 French Compare
v25 2020-03-30 English Compare
v24 2020-02-15 French Compare
v23 2020-02-15 English Compare
v22 2020-01-08 French Compare
v21 2020-01-08 English Compare
v20 2019-12-10 French Compare
v19 2019-12-10 English Compare
v18 2019-10-29 French Compare
v17 2019-10-29 English Compare
v16 2019-10-15 French Compare
v15 2019-10-15 English Compare
v14 2019-09-10 French Compare
v13 2019-09-10 English Compare
v12 2019-08-06 French Compare
v11 2019-08-06 English Compare
v10 2019-08-06 French Compare
v9 2019-08-06 English Compare
v8 2019-07-03 French Compare
v7 2019-07-03 English Compare

Showing 1 to 20 of 26